TrialRenal failure2026

Efficacy and safety of ferric citrate tablets in Chinese patients with hyperphosphatemia undergoing maintenance hemodialysis: a multicenter, randomized, open-label, active-controlled, phase III trial.

Jie Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.